Please login to the form below

Not currently logged in
Email:
Password:

Myovant Sciences

This page shows the latest Myovant Sciences news and features for those working in and with pharma, biotech and healthcare.

FDA approves Myovant’s oral pill Orgovyx for prostate cancer

FDA approves Myovant’s oral pill Orgovyx for prostate cancer

The US Food and Drug Administration (FDA) has approved Myovant’s once-daily pill Orgovyx for prostate cancer. ... day,” said Lynn Seely, chief executive officer of Myovant Sciences.

Latest news

  • Takeda forms new women's health and cancer company Takeda forms new women's health and cancer company

    Myovant Sciences will focus on delivering innovative therapies in the two areas, with former Medivation chief medical officer Lynn Seely appointed to lead the business. ... For its tie-up with Takeda, the Japanese firm has granted Myovant Sciences an

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....